drugset / Trial / NCT00440245

Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease

NCT00440245

Phase 4 Completed 28 enrolled University of Saskatchewan
NaSingle-groupOpen-labelTreatment

Summary

This study will investigate potential differences in how two puffs of salbutamol protects airway smooth muscle from contracting in people with asthma and chronic obstructive pulmonary disease (COPD).

Timeline

Start
2007-02
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Salbutamol Unknown 200 ug Inhaled